아푸투주맙

아푸투주맙
아푸투주맙 구조식 이미지
카스 번호:
949142-50-1
한글명:
아푸투주맙
동의어(한글):
아푸투주맙;아후투주맙
상품명:
Obinutuzumab
동의어(영문):
Ga 101;Ro5072759;afutuzumab;Ro 5072759;Humab(cd20);Obinutuzumab;Obinutuzumab/afutuzumab;Obinutuzumab (anti-CD20);Research Grade Obinutuzumab(DHC90704);Inhibitor,GA 101,Anti-Human CD20 type II, Humanized Antibody,inhibit,GA101,Obinutuzumab,GA-101
CBNumber:
CB81518489
분자식:
포뮬러 무게:
0
MOL 파일:
Mol file

아푸투주맙 속성

물리적 상태
Liquid
색상
Colorless to light yellow

안전

유해 물질 데이터 949142-50-1(Hazardous Substances Data)

아푸투주맙 C화학적 특성, 용도, 생산

개요

In November 2013, the US FDA approved the glycoengineered, type II anti-CD20 antibody obinutuzumab (also known as GA101) in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL). Obinutuzumab is the first drug approved under the FDA’s breakthrough therapy designation, created in 2012 to quicken the pace of development and review of drugs for serious conditions. The Fc portion of obinutuzumab was glycoengineered to reduce fucosylation of the Fc carbohydrate, resulting in increased FcγRIIIa affinity and antibody-dependent cellular cytotoxicity (ADCC) potency. As expected for a type II antibody, obinutuzumab demonstrated lower complement-mediated cytotoxicity, more potent mediation of cell death via the nonclassical apoptosis pathway and increased ADCC as compared with rituximab in preclinical studies. In addition, obinutuzumab induced a stronger antitumor effect in mouse xenograft models of human lymphoma than rituximab and ofatumumab, supporting clinical investigation of this third generation anti-CD20 antibody.

Originator

GlycArt Biotechnology AG (United States)

상표명

Gazyva

아푸투주맙 준비 용품 및 원자재

원자재

준비 용품


아푸투주맙 공급 업체

글로벌( 28)공급 업체
공급자 전화 이메일 국가 제품 수 이점
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
Wuhan Sunrise Technology Development Co., Ltd. 027-027-83314682 13554138826
whsrtech@vip.163.com China 85 62
Dalian Meilun Biotech Co., Ltd. 0411-62910999 13889544652
sales@meilune.com China 4667 58
LUCKY PHARMA CO., LIMITED 0571-86403260 86403970
lucky@lkbiology.com China 243 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9707 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
2853530910@QQ.com China 8013 62
Twochem Co.Ltd. 021-58111628 15800915896
sales@twochem.com China 1789 58
Tianjin Kaifu Pharmaceutical Technology Co., Ltd. 18081075745
chemflowtech@sina.com China 1886 58

Copyright 2019 © ChemicalBook. All rights reserved